HIV/AIDS Researchers Meet to Explore Vaccine Developments and Alternate Treatment and Prevention Strategies

New York Academy of Sciences symposium will follow National HIV Vaccine Awareness Day.

Published April 28, 2010

The Global HIV Vaccine Enterprise and the New York Academy of Sciences will present HIV/AIDS: Vaccines and Alternate Strategies for Treatment and Prevention, a daylong meeting at the New York Academy of Sciences on May 19, 2010. One day after National HIV Vaccine Awareness Day, the meeting will convene leaders in HIV vaccine R&D to discuss and propose solutions to the range of challenges they face, including developing HIV vaccines to prevent or control infection, understanding genetic diversity of the virus, and developing predictive models of infection. The symposium will also cover other non-scientific challenges and mechanisms that can be used to reduce HIV transmission now and in conjunction with a future vaccine.

  • WHAT: HIV/AIDS: Vaccines and Alternate Strategies for Treatment and Prevention
  • WHEN: Wednesday May 19, 9:00 am – 5:30 pm
  • WHERE: The New York Academy of Sciences, 250 Greenwich St., 40th floor, New York
  • WHO: Organized by Sarah Schlesinger, The Rockefeller University; Yegor Voronin, Global HIV Vaccine Enterprise; and Jennifer Henry, The New York Academy of Sciences
  •  

  • Speakers and topics include:
  • Genetic Diversity in HIV: Dan Barouch, Associate Professor of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, and Michael Worobey, Associate Professor, Department of Ecology and Evolutionary Biology, University of Arizona.
    Neutralizing Ab Reactions to HIV: Sanjay Phogat, Principal Scientist, International AIDS Vaccine Initiative, and Susan Zolla-Pazner, NYU Langone School of Medicine.
    Non-human Primate Models: Louis Picker, Oregon Health & Science University, and Christopher Miller, Professor of Pathology, Microbiology, and Immunology, University of California, Davis, School of Veterinary Medicine and Adjunct Professor of Medicine, University of California, Davis, School of Medicine.
    Human Clinical Trials: Julie McElrath, Member of the Fred Hutchinson Cancer Research Center and Professor in the University of Washington Department of Medicine; and Harriet Robinson, Chief Scientific Officer, GeoVax Inc.
    Ethical Guidelines and Clinical Trials: Jerome Kim, Deputy Director (Science) and Chief, Department of Molecular Virology and Pathogenesis, Division of Retrovirology, Walter Reed Army Institute of Research (U.S. Military HIV Research Program).

    The meeting will conclude with a panel discussion on the topic, “Where Are We Going and What's Next?” A networking reception will follow.

    For more information or to register for the symposium, please go to the conference website. Media coverage of this meeting is encouraged. To register, please contact Adrienne Burke at aburke@nyas.org, (212) 298-8655.